Renal No adjustment needed; monitor closely for anticholinergic effects if CrCl <60 mL/min
Hepatic No adjustment needed (not studied)
Do not exceed one dose (two inhalations) per 24 hours
Instructions
For oral inhalation only; do not swallow capsules
Use capsules only with the HandiHaler device
Not a rescue medication; not for acute bronchospasm
Do not take more than one dose in 24 hours
Available strengths
powder 0.018 mg/inh
cap 18 mcg
spray 1.25, 2.5 mcg/inh
Contraindications
Hypersensitivity to tiotropium, ipratropium, or product components (including angioedema)
Cautions
Not for acute use/rescue
Immediate hypersensitivity reactions including angioedema; caution with severe milk-protein hypersensitivity
Paradoxical bronchospasm
Worsening of narrow-angle glaucoma
Worsening of urinary retention
Adverse reactions
Upper respiratory tract infection
Dry mouth
Sinusitis, pharyngitis
Non-specific chest pain
Urinary tract infection, dyspepsia, rhinitis
Pregnancy Limited human data insufficient to inform risk
Lactation No human data; present in milk of lactating rats
Cost
Tiotropium (SPIRIVA)
Strength
#/mo
generic $/unit
CostPlus
0.018 mg/inh
powder
per unit
not offered
NADAC is a voluntary CMS survey of what retail community pharmacies pay for the drugs they stock. Tiotropium is dispensed outside retail pharmacies, so it rarely appears on surveyed invoices.